ProSomnus, Inc. Common StockShare · US50535E1082 · OSA (XNAS) — real-time quotes, company data, dividends, fundamentals, and AI-powered portfolio analysis on MoneyPeak
Find out what the numbers really say — before the market does
Analyze now
News Sentiment
Are today's headlines a buy signal or a red flag?
Analyze now
Buy / Hold / Sell
Should you Buy, Hold, or Sell? Get the AI verdict now.
Analyze now
Risk Assessment
Uncover hidden risks before they hit your portfolio.
Analyze now
Fair Value
Is this stock cheap, fairly priced, or overvalued?
Analyze now
Últimos análisis de IA sobre ProSomnus, Inc. Common Stock
Resumen de la Calificación de Analistas
Comprar
Compra Fuerte
Comprar
Mantener
Vender
Venta Fuerte
0
1
1
0
0
Sin cotización
Flotación y Liquidez de las Acciones
Flotación Libre46,49 %
Acciones en Flotación8,09 M
Acciones en Circulación17,39 M
Perfil de la empresa para ProSomnus, Inc. Common Stock Acción
ProSomnus, Inc. operates as a medical technology company that develops, manufactures, and markets precision intraoral medical devices for treating and managing patients with obstructive sleep apnea. The company sells its products to sleep dentists, sleep physicians, primary care providers, otolaryngologists, and other integrated healthcare service providers through a direct sales force. ProSomnus, Inc. is headquartered in Pleasanton, California. On May 7, 2024, ProSomnus, Inc., along with its affiliates, filed a voluntary petition for reorganization under Chapter 11 in the U.S. Bankruptcy Court for the District of Delaware.